U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. MENVEO
  1. Vaccines

STN: 125300
Proper Name: Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
Tradename: MENVEO
Manufacturer: GlaxoSmithKline Biologicals SA
Indication:

  • MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons aged 2 months through 55 years. MENVEO does not prevent N. meningitidis serogroup B infections.

Product Information

Supporting Documents